Last reviewed 2026-04-20 · How we verify

SOLRIAMFETOL HYDROCHLORIDE

At a glance

Approved indications

No approved indications tracked.

Common side effects

• Headache
• Nausea
• Decreased appetite
• Insomnia
• Anxiety
• Bruxism
• Diarrhea
• Dry mouth
• Weight decreased
• Cough
• Agitation
• Irritability

Serious adverse events

• Palpitations
• Dyspnea
• Constipation
• Vomiting

Key clinical trials

• A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness (PHASE2)
• "Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" (PHASE3)
• "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy" (PHASE3)
• "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" (PHASE3)
• "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA" (PHASE3)

Patents

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.